Table 1. General clinical characteristics of the study cohorts.
Phenotype | SHS | CoLaus | GerMIFS |
---|---|---|---|
No. of subjects | 629 | 5478 | 3030 |
No. of families | 207 | 0 | 1261 |
No. of men (%) | 313 (49.8) | 2,612 (47.7) | 1,835 (60.6) |
Age, years | 45.8±15.7 | 53.2±10.8 | 59.1±10.7 |
BMI, kg/m2 | 26.8±4.7 | 25.8±4.6 | 27.2±3.9 |
LDL-cholesterol, mmol/l | 4.0±1.10 | 3.47±1.01 | 4.17±1.14 |
HDL-cholesterol, mmol/l | 0.98±0.29 | 1.63±0.44 | 1.36±0.38 |
Triglycerides, mmol/l | 1.76±1.10 | 1.40±1.21 | 2.19±1.42a |
Lipid-lowering medication (%) | 0 | 472 (8.6) | Excluded |
Abbreviations: CoLaus: population-based cohort of Lausanne; GerMIFS: German Myocardial Infarction Family Study; SHS: Silesian Hypertension Study.
Data are means±SD or counts and percentages.
Non-fasting.